Results 101 to 110 of about 3,595 (167)

Improving Access to Outpatient Antibiotic Therapy: Addition of Dalbavancin to a County Hospital Formulary for Complicated Staphylococcus aureus Infections. [PDF]

Cureus
Butt S, Tieman M, Kressel AB, Weaver B, Kays M.   +4 more
europepmc   +1 more source

Long-Term Therapy with Long-Acting Lipoglycopeptide Antibiotics in the Treatment of Cardiovascular Prosthetic Infections: A Systematic Review. [PDF]

Antibiotics (Basel)
Gavaruzzi F, Granata G, Capone A, Chinello P, Cicalini S.   +4 more
europepmc   +1 more source

Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections. [PDF]

Antimicrob Agents Chemother
Benavent E, Lora-Tamayo J, Ulldemolins M, Pons-Oltra P, Gregoire M, Mancheño-Losa M, Hernández-Jiménez P, Meléndez-Carmona MÁ, Casals V, Roberts JA, Rigo-Bonnin R, Murillo O.   +11 more
europepmc   +1 more source

A bundle of the top 10 OPAT publications in 2024. [PDF]

Antimicrob Steward Healthc Epidemiol
Childs-Kean LM, Azimi SF, Beieler AM, Castellino L, Keller SC, Pertzborn M, Yamshchikov A, Yoke LH, Young K, Mahoney MV.   +9 more
europepmc   +1 more source

Diphtheria-like Pseudomembranous <i>Corynebacterium striatum</i> Chronic Infection of Left Ventricular Assist Device Driveline Bridged to Heart Transplantation with Dalbavancin Treatment. [PDF]

Reports (MDPI)
Lupia T, Casarotto M, Mornese Pinna S, Corcione S, Bondi A, Boffini M, Rinaldi M, De Rosa FG.   +7 more
europepmc   +1 more source

Gerbode defect resulting from ineffective treatment of infective endocarditis: a case report. [PDF]

Cardiovasc Ultrasound
Carter KS, Reed P, Gentry J.
europepmc   +1 more source

Methicillin-resistant <i>Staphylococcus aureus</i> and vancomycin-resistant <i>Enterococcus faecium</i> infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data and key evidence gaps. [PDF]

Lancet Reg Health West Pac
Gwee A, Bannister S, Best E, Carr J, Harwood K, Lai T, Lei A, Lutui F, McMullan B, Mostaghim M, Voss L, Weerdenburg H, Williams P, Wilkins A, Yeoh D, KIDS DOSE group.   +15 more
europepmc   +1 more source

Long-acting glycopeptides: what are the barriers to access in patients who need them most, and how can they be overcome? [PDF]

J Antimicrob Chemother
MacPhail A, Attwood LO, Rogers BA.
europepmc   +1 more source

Are Oritavancin and Dalbavancin More Cost Effective for Outpatient Parenteral Antimicrobial Therapy at a Veterans Affairs Medical Center? [PDF]

Fed Pract
Hanks D, Jodlowski TZ, Madaras-Kelly K, Diaz J, Vietri N.   +4 more
europepmc   +1 more source